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A B S T R A C T
Background: Coronary artery disease (CAD) occurs at younger age in India but only a limited number of
studies have evaluated risk factors and management status. This is a multisite observational registry to
assess risk factors and treatment patterns in young patients presenting with acute coronary syndrome
(ACS) and stable ischemic heart disease (IHD).
Methods: We recruited 997 young patients (men <55, women <65 y) presenting with ACS or stable IHD
successively at 22 centers across India. Details of baseline risk factors and management status were
obtained. Descriptive statistics are reported.
Results: Mean age of participants was 49.1 8y, 72% were men and 68% had ACS. Family history of CAD
was in 50%, diabetes 44%, hypertension 49%, history of dyslipidemia 11%, smoking/tobacco use 39%, and
sedentary habits in 20%. 1.3% had “possible familial hypercholesterolemia”. Metabolic risk factors (high
BMI, diabetes and hypertension) were signiﬁcantly greater in women (p < 0.01). Women were older at
diagnosis of CAD and presented more often with non-ST elevation ACS. In the study cohort antiplatelet
use was in 85%, beta-blockers 38%, statins 63% and ACE inhibitors/ARBs in 41% while in ACS patients it was
80.5%, 54.6%, 80.8% and 40.8%, respectively. 35.9% patients underwent percutaneous coronary
intervention while coronary bypass surgery was performed in 10.4%.
Conclusions: Conventional risk factors including family history continue to play a pivotal role in
premature CAD in Indians. Women have more of metabolic risk factors, present at a later age and have
non-ST elevation ACS more often. There is a need to focus on improving use of evidence-based drug
therapies and interventions.
ã 2016 Published by Elsevier B.V. on behalf of Cardiological Society of India. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Cardiovascular diseases (CVD) are the most important causes of
mortality and morbidity in India1. Global Burden of Diseases (GBD)
Study has reported that from year 1990 to 2013, IHD in India
increased to become number 1 cause of death2. This study also
reported that number of patients with IHD increased from less* Corresponding author.
E-mail address: ssiyengar1945@gmail.com (S.S. Iyengar).
http://dx.doi.org/10.1016/j.ihj.2016.09.009
0019-4832/ã 2016 Published by Elsevier B.V. on behalf of Cardiological Society of
creativecommons.org/licenses/by-nc-nd/4.0/).
Please cite this article in press as: S.S. Iyengar, et al., Premature coronary
registry, Indian Heart J (2016), http://dx.doi.org/10.1016/j.ihj.2016.09.00than a million to 2 million. IHD in India is characterized by
increasing numbers, regional variations, premature onset, poor
management and greater mortality1,3.
Premature IHD can have devastating consequences for the
individual, the family, and the society4. INTERHEART study
reported that 9 standard risk factors- dyslipidemia (high apolipo-
protein B/apolipoprotein A1 ratio), smoking, hypertension, diabe-
tes, high waist-hip ratio, unhealthy diet, low physical activity,
irregular alcohol consumption and psychosocial stress- explained
more than 90% of the ﬁrst acute myocardial infarction5. Premature
IHD in the South Asian region was explained due to premature India. This is an open access article under the CC BY-NC-ND license (http://
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Table 1
Socio-demographic characteristics.
Total Male Female
Age, years – Mean (SD) 49.07 (8) 46.67 (7) 55.14 (7)
Psychosocial (n %)
Excellent 44 (4) 28 (4) 16 (6)
Good/Fair 937 (94) 675 (95) 262 (93)
Poor 11 (1.10) 6 (0.84) 5 (1.76)
Socioeconomic characteristics (n %)
Upper 87 (9) 74 (10) 13 (5)
Middle 755 (76) 570 (80) 185 (65)
Lower 139 (14) 64 (9) 85 (30)
2 S.S. Iyengar et al. / Indian Heart Journal xxx (2016) xxx–xxx
G Model
IHJ 1087 No. of Pages 6onset of the same biological risk factors in the INTERHEART study6.
Smaller case-control studies in India have reported importance of
these risk factors7. A case-control study highlighted importance of
thrombotic (smoking, low fruit/vegetables intake, ﬁbrinogen,
homocysteine) as well as atherosclerotic (hypertension, high fat
diet, dyslipidemia) risk factors in causing premature IHD8. Quality
of care of acute coronary syndrome (ACS) patients in India has been
reported in large registries. The nationwide CREATE registry
(n = 20468) reported that use of evidence based medical drugs
(thrombolytics, beta-blockers, antiplatelets, RAAS blockers and
statins) as well as revascularization (coronary interventions or
surgery) was low9. Similar results were reported in Kerala ACS
registry (n = 25748)10 and multicenter DEMAT11 and SPREAD12
registries. However, all these studies were focused in all age-
groups and not in premature IHD patients. We undertook a multi-
centric, prospective, observational study across India to ﬁnd out
possible risk factors associated with CAD among young Indian
population. The study included not only patients of ACS but also
patients with stable IHD, and analyzed different treatment
strategies.
2. METHODS
Coronary Artery Disease in the Young (CADY) is a prospective
observational study to examine the risk factor proﬁle and
management strategies in premature CAD in a cohort of Indian
patients. 997 patients were recruited in 22 participating centers
between November 2010 and January 2012. The centers are
distributed across India, more from South India (Fig. 1). Men less
than 55 years of age and women less than 65 years presenting with
CAD or those with established CAD on follow up were included in
the study. The diagnosis of CAD was made by a positive stress test
or a deﬁnite imaging technique. Patients who had prior PTCA or
CABG were also included in the study. Ethics clearance was
obtained from the central coordinating unit and individual sites.
Informed consent was obtained from all patients.Table 2
Associated Risk Factors.
Charactertistics CAD n (%) 
997 
Age 49.1  8 
Diabetes Mellitus 441 (44.23) 
Hypertension 492 (49.35) 
Dyslipidemia 114 (11.43) 
Psychosocial (fair and poor) 559 (56.07) 
Physical activity (low) 195 (19.56) 
Socioeconomic characteristics (upper) 87 (8.73) 
Socioeconomic characteristics (Middle) 755 (75.73) 
Socioeconomic characteristics (Lower) 139 (13.94) 
Family history (Positive) 495 (49.65) 
Substance Use (Tobacco) 385 (38.62) 
Waist circumference 362 (36.31) 
Body Mass Index (23) 562(56.37) 
Note: P < 0.05 implies signiﬁcant difference between proportions.
Please cite this article in press as: S.S. Iyengar, et al., Premature coronary
registry, Indian Heart J (2016), http://dx.doi.org/10.1016/j.ihj.2016.09.00The data collection was performed either by the designated
staff or trained research coordinators. Demographic data regarding
socioeconomic status and age were collected. Medical history of
associated risk factors such as hypertension, diabetes, dyslipide-
mia, stroke and peripheral vascular disease were documented.
Data on lifestyle factors such as diet, smoking, non-smoked
tobacco use, alcohol consumption, exercise patterns and psycho-
social factors were also obtained. Data regarding socioeconomic
status was obtained using Kuppuswami classiﬁcation13 and for
psychosocial stress we used the modiﬁed INTERHEART question-
naire14. Details of hospitalization including diagnostic tests,
medications and laboratory tests were obtained from hospital
records. Dutch lipid clinic network (DLCN) criteria was used to
identify patients with familial hypercholesterolemia. TIMI score
for patients with non-Q ACS15 were also calculated during
hospitalization. Treatment advice at discharge was noted from
the hospital records. Although the study was designed to gather
follow-up information up to 24 months after enrolment this report
is restricted to the data available at discharge.
2.1. Statistical analyses
All the data were computerized and data analysis performed
using EpiInfo programme. Descriptive statistics are reported.
The study is registered with Clinical Trials Registry of India at
www.ctri.nic.in (CTRI/2012/12/003232).
3. Results
Patient enrolment was performed in different parts of the
country to cover various geographical regions. Of the 997
participants, 714 (72%) were men. Mean age of study participants
was 49.1 years, 46.7 years in men and 55.1 years in women. Out of
997 patients, 680 (68%) had ACS and 317 (32%) stable IHD. Of the
680 ACS patients, 51% had ST-elevation myocardial infarction
(STEMI) and 49% had NSTE-ACS. According to the universal
deﬁnition of myocardial infarction16, it was determined that 3
patients had type-2, 2 had type-4b and the rest had type-1
infarctions. Of these, 348 had STEMI and 158 had non-STEMI. 57.6%
of patients with NSTE-ACS had a TIMI score of 3 or greater.
Socio-demographic characteristics and associated risk factors
are shown in Tables 1 and 2. 75.6% of participants belonged to
middle socioeconomic status. Moderate to high psychosocial stress
level was reported in 55.9% of the study population. Family history
of premature IHD was present in half of the participants (49.6%)
and was more in men (72.3%) as compared to women (27.7%).
Signiﬁcant proportion of participants had modiﬁable risk factors:
hypertension 49.3%, diabetes 44.2%, dyslipidemia 11.4%, smokingMale n (%) Female n (%) P-value
714 283
46.67  7 55.1  7 <0.001
265 (37.11) 176 (62.19) <0.0001
288 (40.34) 204 (72.08) <0.0001
76 (10.64) 38 (13.43) 0.2119
403 (56.44) 156 (55.12) 0.7050
120 (16.80) 75 (26.50) 0.0005
74 (10.36) 13 (4.59) 0.0036
570 (79.83) 185 (65.37) <0.0001
64 (8.96) 85 (30.04) <0.0001
358(72.32) 137 (27.68) 0.6241
376 (52.66) 9 (3.18) <0.0001
251(35.15) 111 (39.22) 0.2301
395 (55.32) 167 (59.01) 0.2891
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Fig. 1. Comparison of Risk factors.
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sedentary habits in 19.5%. 210 (21%) patients had previous
coronary interventions (PCI) or coronary bypass surgery, 14
(1.4%) peripheral arterial disease and 11 (1.1%) had stroke. Women,
as compared to men, had greater prevalence of diabetes (62.1 vs
37.1%, p < 0.001), hypertension (72.1 vs 40.3%, p < 0.0001) and
overweight/obesity (60.1 vs 35.2%, p < 0.0001), whereas men had
greater prevalence of smoking/tobacco use (52.7 vs 3.2%, p
< 0.0001). “Possible Familial Hypercholesterolemaia” (FH) was
diagnosed in 13 (1.3%) patients applying DLCN criteria, mean age
being 55.07 years, 08 were male patients and 10 had ACS and
others stable IHD.
Details of therapies are provided in Table 4. In the overall group,
834 (83.7%) received antiplatelet drugs (aspirin and/or clopidog-
rel), 632 (63.5%) statins, 413 (41.4%) ACE inhibitors/ARBs, and 386
(38.7%) beta blockers. Calcium channel blockers were prescribed in
94 (9.43%) patients and nitrates in 149 (14.9%). 358 (35.91%)
underwent percutaneous coronary intervention, 261 (36.55%)
being male and 97 (34.28%) being female patients. 104 (10.43%)
underwent coronary bypass surgery.
In the hospitalized group of 735 patients, 649 had ACS and 86
had stable IHD. 561(86.2%) patients of ACS stayed in the hospital
for 1–7 days, 29.3% for less than 48 hours. 42(43.7%); patients of
stable IHD were in the hospital for 1–7 days, and 18.6% for less than
48 hours.
4. Discussion
This study shows that prevalence of standard coronary risk
factors (smoking, hypertension, diabetes and dyslipidemia) is high
in premature CAD in India and is similar to previous case-control
studies from the country4 and registries (Fig. 1) Women with
premature CAD have greater prevalence of metabolic risk factors as
compared to men. High prevalence of family history, especially in
men, is a unique ﬁnding and suggests importance of genetic
factors17. This study also shows a low use of evidence-based
therapies in ACS.
CREATE9, Kerala-ACS10 DEMAT11 and SPREAD study12 registries
have provided information on coronary atherosclerotic risk factors,
treatment patterns and outcomes in Indian populations. However,
these studies included all age groups and only patients of ACS.
Kerala ACS study was conﬁned to the Kerala state population. The
present study, a multisite, prospective registry included patients
with ACS as well as patients with stable IHD from different states of
the country, which would give a better overall view of the burden
of CAD in the country. Moreover, this study focused on premature
CAD, a major concern for patients, practitioners and policy makersPlease cite this article in press as: S.S. Iyengar, et al., Premature coronary
registry, Indian Heart J (2016), http://dx.doi.org/10.1016/j.ihj.2016.09.00in India. In the present study, of the 997 patients, 68% had ACS and
32% had stable IHD. Prevalence of premature stable IHD is an
underestimate. On the basis of studies in US, it was estimated that
there are 30 patients of stable IHD for every patient with ACS18. The
situation is likely to be no different in our country and that gives an
idea of the magnitude of the burden of premature IHD. Of the 680
ACS patients, 51% had STEMI and 49% had NSTE-ACS. In the CREATE
registry STEMI was in 61% and the gap between numbers of STEMI
and NSTE ACS has narrowed in the present study. Secular trends in
awareness and treatment of risk factors and better management of
stable IHD in India may have contributed to this “evolution” in CAD
epidemiology. On the other hand, in the Kerala-ACS registry, STEMI
rates were lower (37%) as compared to NSTE-ACS (63%). Kerala
state which has the highest literacy rate in the country has
probably marched much ahead in terms of epidemiological
evolution.
Almost half of the study participants have history of premature
CAD in the family. Parental historyof premature CADhas been shown
to be an important, independent, consistent and global determinant
of future MI risk17. This associationwas not affected after adjustment
for age-, sex-, region, and the 9 INTERHEART risk factors. High
prevalence of family history, especially in men, points to presence of
genetic factors inprematureCADinIndia.Althoughtherearenolarge
association studies of genetic factors with coronary atherosclerosis
or ACS in India, studies among emigrant South Asians have reported
that a few genetic markers are important. The markers with
signiﬁcant associations include 9p21 genotypes and a few single
nucleotidepolymorphisms.Largestudiesfor identiﬁcationofgenetic
markers are required among premature IHD patients. Meanwhile,
clinicians caring for CAD patients should screen the close relatives of
the patient for family history of premature CAD. Other risk factors
included diabetes in 44%, hypertension in 49%, history of dyslipi-
demia in 11%, smoking/tobacco use in 39%, low physical activity in
20%, high BMI 23 kg/m2 in 56% and high waist circumference in
42%.Theseratesaresimilartopreviouscase-controlstudiesalthough
the INTERHEART study reported that dyslipidemia was the most
important risk factor.
FH is underdiagnosed and undertreated, as the awareness is
poor amongst medical and nonmedical communities. FH is a
common genetic disorder, with global prevalence being 1 in 200,
and is a common cause for premature CAD. From various criteria
that are available for diagnosis of FH – MEDPED criteria, Dutch
Lipid Clinic Network(DLCN) criteria, Simon Broom criteria, and
Japanese criteria – DLCN criteria18 was applied to identify FH in
this patient population. This takes into consideration family
history, clinical history and ﬁndings, serum LDL-C levels and
genetic testing. No genetic tests were carried out in our patients. artery disease in India: coronary artery disease in the young (CADY)
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PCSK-9 is generally poor. In a study19 where genes were sequenced
in 1,26,025 participants, it was seen that FH was detected in <2% of
participants who had a serum LDL-C level of >190 mg%. Impor-
tantly, at any level of LDL-C, the CV risk is higher in subjects with
mutation.
“Possible FH” was identiﬁed in 13(1.3%) patients. It is probably
an underestimation for various reasons. Firstly, it was not
prospectively and actively sought for. Only on a sound suggestion
from a reviewer, this was done. Some of these patients were
already on statins, altering the serum LDL-C values. Markers like
xanthomas could have been missed. Genetic tests were not carried
out. Clinical criteria may not be sufﬁcient to assess prevalence of
FH20. “Possible FH” have mutation in 20–30% of subjects. Since
premature CAD is a major problem in our country and FH is
probably one of the reasons, it is necessary to look for FH in our
population.
There is clearly a need to improve the utilization of evidence
based drug therapy in patients with CAD, especially premature
CAD in India. Availability of generic drugs and combination pills in
the market are likely to enhance evidence based practice and
adherence to therapy. We have observed that 46.1% of patients
underwent PCI or CABG. Appropriateness of the procedures has not
been analyzed. However, when we look at the NSTE-ACS patients,
57.6% had a TIMI score of 3 or more, making them eligible for
intervention (Fig. 2). Once the diagnosis of CAD is established,
appropriate treatment has to be instituted. Use of all the drugTable 3
Distribution of patients falling in each characteristics by disease status.
Characteristics – n (%) Total 
997 
Diabetes Mellitus 441 (44.2
Hypertension 492 (49.3
Dyslipidemia 114 (11.43
Psychosocial (fair and poor) 559 (56.0
Physical activity (low) 195 (19.5
Substance Use (Tobacco) 385 (38.6
Waist circumference ((Females 80 cm and males 90 cm)) 421 (42.2
Body Mass Index ( 23) 562 (56.3
Family history (positive) 495 (49.6
Socioeconomic characteristics
Upper I 87 (8.73) 
Upper Middle II 454 (45.5
Lower Middle III 301 (30.1
Upper Lower IV 138 (13.8
Lower 11 (1.1) 
Please cite this article in press as: S.S. Iyengar, et al., Premature coronary
registry, Indian Heart J (2016), http://dx.doi.org/10.1016/j.ihj.2016.09.00classes is suboptimal (Table 4) but is similar to CREATE and Kerala-
ACS. Prospective Urban Rural Epidemiology (PURE)21 as well as
Andhra Pradesh Rural Health Initiative (APRHI)22 studies have
reported that treatment levels for secondary prevention in urban
and rural areas in India are disappointing. In APRHI study use of
aspirin, beta-blockers, ACE inhibitors/ARBs, and statins was
severely underutilized. Of the patients with ischemic heart disease,
fewer than 16%, 25%, 10%, and 6% were using aspirin, b-blockers,
ACE inhibitors, and statins respectively.
Dual antiplatelet therapy (DAPT) was received by 473 patients
(all 358 patients undergoing PCI receiving DAPT), and 361 were on
single antiplatelet.
The hospitalization period does appear longer than expected –
only 29.3% of ACs patients and 18.6% of stable IHD patients staying
in the hospital for less than 48 hours. The study did not look into
the factors leading to prolonged hospitalization of these patients.
The lack of health insurance coverage in the majority of patients,
referral from and to other disciplines in the hospital for cardiac and
non-cardiac evaluation and complications following interventions
are possible explanations for a prolonged hospital stay.
4.1. Any thing new?
Though this study conﬁrms the ﬁndings of the previous studies
as regards CAD risk factors, there are two aspects which we feel
should be communicated to the medical and non-medical
community with renewed emphasis.ACS Stable IHD P- Value
680 (68.20) 317 (31.80)
3) 280 (41.18) 161 (50.79) 0.0044
5) 320 (47.06) 172 (54.26) 0.0340
) 135 (19.85) 61 (19.24) 0.8181
7) 360 (52.94) 199 (62.78) 0.0036
6) 148 (21.76) 47 (14.83) 0.0102
2) 271 (39.85) 114 (35.96) 0.2380
3) 326 (47.94) 95 (29.97) <0.0001
7) 394 (57.94) 168 (53) 0.1416
5) 337 (49.56) 158 (49.84) 0.9362
65 (9.56) 22 (6.94) 0.1738
4) 299 (43.97) 155 (48.9) 0.1471
9) 215 (31.62) 86 (27.13) 0.1499
4) 87 (12.79) 51 (16.09) 0.1615
9 (1.32) 2 (0.63) 0.3320
 artery disease in India: coronary artery disease in the young (CADY)
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Table 4
Drug therapies in acute coronary syndrome and stable IHD groups.
Evidence based drugs Total
997
n (%)
Acute coronary syndrome
680
n (%)
Stable IHD
317
n (%)
p value
Antiplatelet drugs 835 (83.7) 544(80.5) 291(91.8) <0.0001
ACE inhibitors/ARBs 413 (41.4) 244(35.9) 169 (53.3) <0.0001
Beta blockers 386 (38.7) 371(54.6) 15(4.7) <0.0001
Statins 637 (63.5) 549(80.8) 88(27.7) <0.0001
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Various aspects of CAD, including epidemiology and clinical
manifestations differ between men and women, and these
differences are explained by biological factors like hormonal
inﬂuence, and socio-cultural processes, like gender bias23. Women
have clinical CAD presenting about 10 years later than it does in
men. That means women have an additional period of 10 years to
practise preventive measures to effectively counter CAD. The
INTERHEART study (5) showed hypertension and diabetes were
more important risk factors in young Indian women than men. And
this study showed women to have more comorbidities like
hypertension, diabetes, dyslipidemia and obesity, which are
amenable to corrective preventive measures. Smoking amongst
female population, is less prevalent, a characteristic feature which
they would do well to retain and improve further. Women have a
wider window of opportunities for prevention of premature CAD.
GUSTO IIb (Global Use of Strategies to Open Occluded Coronary
Arteries in Acute Coronary Syndromes), TIMI IIIB (Thrombolysis In
Myocardial Infarction), and the Euro Heart Survey studies showed
that women present more frequently with unstable angina and
non–ST-elevation myocardial infarction (NSTEMI), whereas men
have ACS with ST elevation (STEMI).24–26 It has been shown that
women are less likely to undergo reperfusion therapy after
ACS.27,28 In our study, women had NSTE-ACS more often than
men (42% vs 29.8%), though not adjusted for age, and there was no
gender bias in interventional treatment.
4.1.2. ACS vs Stable IHD
In case of secondary prevention of CAD, it is worth emphasizing
another step – “Prevent stable IHD progressing to ACS”. The
conventional risk factors for CAD account for 90% of acute cardio-
vascular events.5 The conventional risk factors for the development
of CAD – hypertension, hypercholesterolaemia, diabetes, sedentary
life-style, obesity, smoking and a family history have an adverse
inﬂuence on prognosis in those with established disease, since they
inﬂuence the progression of atherosclerotic disease process.
Appropriate intervention, if instituted can reduce the risk. Once
the primary prevention fails, and the patient develops stable IHD, we
should strive to prevent its progression to ACS, which would reduce
mortality, morbidity and associated economic and psycho-social
burden. The message is “If you fail to prevent the development of an
atheromatous plaque, then preserve the stability of the atheroma-
tous plaque”. Prevention of progression of the atheromatous plaque
or even regression of the atheromatous plaque is a reality now, with
effective secondary preventive measures.
Comparison between patients of ACS and stable IHD (Table 3)
showed that low physical activity and increased waist circumfer-
ence were signiﬁcantly more common in patients with ACS, while
diabetes, hypertension and lower psycho-social class were more
frequent with stable IHD. Inﬂammatory markers (like hsCRP) were
not assessed in the study, and the study is not equipped to explain
these points. However, it is not inappropriate to surmise that
physical activity and central obesity probably received less
attention, while patients with diabetes and hypertension were
adequately managed.Please cite this article in press as: S.S. Iyengar, et al., Premature coronary
registry, Indian Heart J (2016), http://dx.doi.org/10.1016/j.ihj.2016.09.00Framingham study29 has shown that aggressive life style
measures reduce events in stable IHD. What we know from clinical
studies is that aspirin, beta blockers, statins, ACE inhibitors and
therapeutic life style changes reduce mortality in stable IHD and so
do the appropriately instituted revascularization procedures.
Before these measures were widely applied, the annual mortality
rate in patients with stable IHD was 4.5%, and now it is 1–3%.30
The usage of drugs was suboptimal, as mentioned earlier.
Antiplatelets and ACE-I/ARB’s were more frequently used in stable
IHD patients than in ACS patients, while the use of BB and statins
were more frequent in patients with ACS than in patients with
stable IHD (Table 4), clearly indicating the urgent need to improve
the awareness and practice of evidence based therapy.
Limitations of the study include the inherent limitations of
registries such as biases because of regionality, gender-represen-
tation, and risk factor assessments as reported above. The follow
up was also not adequate to comment on outcomes and adherence
to therapy. On the other hand, this multi-centric observational
registry of premature CAD in Indians indicates that the conven-
tional risk factors are important and there is an urgent need to
focus on these risk factors in primary and secondary prevention.
5. Conclusion
This multi-centric observational registry of premature CAD in
Indians indicates that the conventional risk factors continue to be
the major cause of CAD in the young. There is an urgent need to
focus on these risk factors in primary and secondary prevention. It
should not be difﬁcult to correct underuse of life style modiﬁcation
and drugs. Effective secondary prevention would ensure stability
of stable IHD. There is a greater scope for preventive practice in the
female population, given the delayed onset of CAD and higher rate
of comorbidities, offering more time and more opportunities.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.ihj.2016.09.009.
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